BACKGROUND: Concerns about the risk-benefit ratio of treatment with antidepressants in the light of recent evidence pointing to a risk of suicide induction during the course of treatment with antidepressants. These concerns have led to a series of recent studies exploring national rates of suicide and correlating these with data on antidepressant consumption. METHODS: We have compared suicide rates in the Nordic countries with autopsy and ill-defined death rates, and antidepressant sales, during the period 1961 through to 2003. RESULTS: There is a close correlation between suicide rates and both autopsy and ill-defined death rates. CONCLUSIONS: The role of autopsies and other factors in the registration of a death as a suicide appear to need further clarification.
BACKGROUND: Concerns about the risk-benefit ratio of treatment with antidepressants in the light of recent evidence pointing to a risk of suicide induction during the course of treatment with antidepressants. These concerns have led to a series of recent studies exploring national rates of suicide and correlating these with data on antidepressant consumption. METHODS: We have compared suicide rates in the Nordic countries with autopsy and ill-defined death rates, and antidepressant sales, during the period 1961 through to 2003. RESULTS: There is a close correlation between suicide rates and both autopsy and ill-defined death rates. CONCLUSIONS: The role of autopsies and other factors in the registration of a death as a suicide appear to need further clarification.